References

Batki, S.L.  Treatment of intravenous drug users with AIDS: 
The role of methadone maintenance. 
Journal
of Psychoactive Drugs
1988 20: 213-216.



Legal Action Center. Beazer vs New York City Transit
Authority: A Landmark Decision on Methadone Maintenance

[Report].  New York:
National Institute on Drug Abuse, 1975.

 

Des
Jarlais, D.C.; Friedman, S.R.; Novick, D.M. et al.  HIV-1 infection among intravenous drug users in Manhattan. 
Journal
of the American Medical Association
1989 261: 1008-1012.

 

Dole,
V.P.; Nyswander, M.E. Heroin addiction: Metabolic disease. Archives of Internal Medicine
1967 120: 19-24.

 

Dole,
V.P.; Nyswander, M.E.  A
medical treatment for diacetylmorphine (heroin) addiction.  Journal of the American Medical Association 1965 (August 23)
193(8): 646-650.

 

Dole,
V.P.; Nyswander, M.E.; Kreek, M.J. 
Narcotic blockade.  Archives
of Internal Medicine
1966 
(October) 118:304-309.

 

Goldstein,
D.  Personal communication,
Eli Lilly Pharmaceuticals, 1992.

 

Joseph,
H; Springer, E.  Methadone
maintenance treatment and the AIDS epidemic. 
In:  The Effectiveness of Drug Abuse
Treatment: Dutch and American Perspectives
. p 261-274. 
Malabar, Florida: Robert E. Krieger, 1990.

 

Kreek,
M.J.  Health consequences
associated with the use of methadone. 
In:  Cooper, J.R.;
Altman, F.; Brown, B.S.; Czechowicz, D. (eds), Research
on the Treatment of Narcotic Addiction: 
State of the Art
(NIDA Research Monograph 83-1201). 
Rockville, MD: National Institute on Drug Abuse, 1983.

 

Platt,
J.J.  Heroin Addiction: 
Theory, Research and Treatment
. 
Malabar, FL:  Kreiger, 1988. 

 

Sells,
S.B.  Effectiveness of Drug Abuse Treatment:
Volume 1 Evaluation of Treatments
. 
Cambridge:  Ballinger,
1974a.

 

 

Sells,
S.B.  Effectiveness of Drug Abuse Treatment:
Volume 2 Research on Patients, Treatments, and Outcomes
. 
Cambridge:  Ballinger,
1974b.

 

Sells,
S.B; Simpson, D.D. The case for drug abuse treatment effectiveness,
based on the DARP research program. British
Journal of Addiction
1980 75: 117-131.

 

Sells, S.B; Simpson, D.D. Effectiveness
of Drug Abuse Treatment: Volume 3 Further Studies of Drug Users,
Treatment Typologies and Assessment of Outcome During Treatment in the
DARP
.  Cambridge: 
Ballinger, 1976a.

 

Sells, S.B.; Simpson, D.D. 
Effectiveness
of Drug Abuse Treatment: Volume 4 Evaluation of Treatment Outcomes for
the 1971-1972 Admission Cohort
. 
Cambridge:  Ballinger,
1976b.

 

Sells, S.B.; Simpson, D.D. 
Effectiveness
of Drug Abuse Treatment: Volume 5 Evaluation of Treatment Outcomes for
the 1972-1973 Admission Cohort
. 
Cambridge:  Ballinger,
1976c.



Goldstein,
D.  Personal communication,
Eli Lilly Pharmaceuticals, 1992.

 

Joseph,
H; Springer, E.  Methadone
maintenance treatment and the AIDS epidemic. 
In:  The Effectiveness of Drug Abuse
Treatment: Dutch and American Perspectives
. p 261-274. 
Malabar, Florida: Robert E. Krieger, 1990.

 

Kreek,
M.J.  Health consequences
associated with the use of methadone. 
In:  Cooper, J.R.;
Altman, F.; Brown, B.S.; Czechowicz, D. (eds), Research
on the Treatment of Narcotic Addiction: 
State of the Art
(NIDA Research Monograph 83-1201). 
Rockville, MD: National Institute on Drug Abuse, 1983.

 

Platt,
J.J.  Heroin Addiction: 
Theory, Research and Treatment
. 
Malabar, FL:  Kreiger, 1988. 

 

Sells,
S.B.  Effectiveness of Drug Abuse Treatment:
Volume 1 Evaluation of Treatments
. 
Cambridge:  Ballinger,
1974a.

Similar Posts

  • |

    Publication

    Admin 03/31/2021

    Sniffing, Snorting Drugs May Raise HCV Risk by Theresa Waldron Reuters Health 4 Jul. 2003 Source: Journal of Medical Virology. 2003;70:387-390. People who snort or sniff heroin in combination with cocaine may be at increased risk of developing the liver infection hepatitis C, according to a new study. Thomas Kresina, a spokesman for the National…

  • About us

    Admin 08/06/2022

    The National Alliance for Medication Assisted Recovery (NAMA Recovery) is an organization comprised of and led by individuals living in medication assisted recovery from opioid use disorder, health care professionals, and family of individuals with opioid use disorder that are supporters of quality, comprehensive treatment that includes medications for opioid use disorder (MOUD). NAMA Recovery…

  • Respond to Mayor Giuliani

    Admin 09/29/2022

     Important Notice Tell Mayor Guiliani How You Feel About His Callous Remarks  On Monday July 20, 1998 during a press conference Mayor Guiliani stated that in 4 years he would close all the methadone programs.  We need your help — this is important not only for New York but because other mayors and governors may…

  • NAMA Policy Statement: Bottle Recall

    Admin 12/30/2021

    The intent of Bottle Recall initially was to be able to allow patients take home medication and to insure that methadone is not diverted to the streets. However, methadone programs have been giving patients take home medication for years without a serious methadone diversion problem. Furthermore numerous studies have demonstrated that methadone is not a…

  • State Ceases Tests to Spot Methadone Misuse

    Admin 06/16/2023

    The Associated Press State & Local Wire, May 3, 2005. DATELINE: Baltimore The state health department has stopped running laboratory tests for Maryland’s methadone clinics, removing a safeguard against misuse of the drug, potentially worsening what authorities say is a growing problem. Methadone, a heroin replacement medication, is used by about 13,400 recovering addicts in…

  • The National Methadone Conference-1

    Admin 02/12/2023

    American Association for the Treatment of Opioid Dependence Washington, D.C. ~ April 13-16, 2003 Honorary Patient Recognition The Honorary Methadone Patient was developed by the National Alliance of Methadone Advocates to recognize those special persons who are not patients but in addition to making significant contributions to the field do so to help patients. Dr….